LGALS3 expression based on
|
KIRC : Kidney renal clear cell carcinoma
Comparison | Statistical significance |
Normal-vs-Primary | <1E-12 |
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer stage information is not available for 2 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Stage1 |
2.95208302247829E-13 |
Normal-vs-Stage2 |
1.578320E-03 |
Normal-vs-Stage3 |
3.46955797425608E-12 |
Normal-vs-Stage4 |
4.77740000004445E-07 |
Stage1-vs-Stage2 |
7.166000E-01 |
Stage1-vs-Stage3 |
1.604820E-01 |
Stage1-vs-Stage4 |
2.271200E-01 |
Stage2-vs-Stage3 |
3.285800E-01 |
Stage2-vs-Stage4 |
3.406800E-01 |
Stage3-vs-Stage4 |
9.724200E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Patient race information is not available for 7 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Caucasian |
<1E-12 |
Normal-vs-AfricanAmerican |
3.796200E-03 |
Normal-vs-Asian |
5.521700E-02 |
Caucasian-vs-AfricanAmerican |
4.510600E-01 |
Caucasian-vs-Asian |
7.381800E-01 |
AfricanAmerican-vs-Asian |
3.146400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Male |
<1E-12 |
Normal-vs-Female |
3.00880000025927E-07 |
Male-vs-Female |
2.657800E-02 |
|
|
KIRC : Kidney renal clear cell carcinoma
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Age(21-40Yrs) |
4.556800E-04 |
Normal-vs-Age(41-60Yrs) |
5.87541126861879E-12 |
Normal-vs-Age(61-80Yrs) |
1.62470037423645E-12 |
Normal-vs-Age(81-100Yrs) |
6.642500E-02 |
Age(21-40Yrs)-vs-Age(41-60Yrs) |
8.631600E-01 |
Age(21-40Yrs)-vs-Age(61-80Yrs) |
9.413800E-01 |
Age(21-40Yrs)-vs-Age(81-100Yrs) |
3.036000E-01 |
Age(41-60Yrs)-vs-Age(61-80Yrs) |
6.620000E-01 |
Age(41-60Yrs)-vs-Age(81-100Yrs) |
2.789400E-01 |
Age(61-80Yrs)-vs-Age(81-100Yrs) |
3.048000E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma Note
Tumor grade information is not available for 3 samples and undetermined for 5 samples.
Subtype descriptions |
Grade 1 | Well differentiated (low grade) |
Grade 2 | Moderately differentiated (intermediate grade) |
Grade 3 | Poorly differentiated (high grade) |
Grade 4 | Undifferentiated (high grade) |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-Grade 1 |
4.751800E-02 |
Normal-vs-Grade 2 |
3.93773902374051E-12 |
Normal-vs-Grade 3 |
5.12029973975814E-10 |
Normal-vs-Grade 4 |
2.30860000005606E-07 |
Grade 1-vs-Grade 2 |
8.408000E-01 |
Grade 1-vs-Grade 3 |
3.689800E-01 |
Grade 1-vs-Grade 4 |
5.358000E-01 |
Grade 2-vs-Grade 3 |
2.027000E-01 |
Grade 2-vs-Grade 4 |
3.845800E-01 |
Grade 3-vs-Grade 4 |
7.919400E-01 |
|
|
KIRC : Kidney renal clear cell carcinoma NOTE
Subtype information is not available for 153 samples.
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-ccA subtype |
1.98729921407903E-14 |
Normal-vs-ccB subtype |
1.69253500104105E-12 |
ccA subtype-vs-ccB subtype |
5.60080000044927E-07 |
|
KIRC subtypes: Brooks SA et al, ClearCode34: A prognostic risk predictor for localized clear cell renal cell carcinoma. Eur Urol. 2014 Jul;66(1):77-84. doi: 10.1016/j.eururo.2014.02.035
|
KIRC : Kidney renal clear cell carcinoma Note
Cancer in nearby lymph nodes cannot be measured (NX) in 277 samples.
pathologic_N descriptions |
N0 | No regional lymph node metastasis |
N1 | Metastases in 1 to 3 axillary lymph nodes |
N2 | Metastases in 4 to 9 axillary lymph nodes |
N3 | Metastases in 10 or more axillary lymph nodes |
Show statistics |
Hide statistics |
Comparison |
Statistical significance |
Normal-vs-N0 |
5.04499775288991E-11 |
Normal-vs-N1 |
8.162300E-02 |
N0-vs-N1 |
3.550800E-04 |
|
|